Navigation Links
Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
Date:1/8/2012

 100008020

Excedrin® Extra Strength  Tablets 300CT New Label

300672030337

10300672030310

0067203033

 100003134

Excedrin® Extra Strength  Tablets 300S

300672030337

10300672030334

0067203033

 100003186

Excedrin® Extra Strength  Tablets 50CT

300672030504

10300672030501

0067203050

 100008009

Excedrin® Extra Strength  Tablets 50CT New Label

300672030504

10300672030501

0067203050

 100006967

Excedrin® Extra Strength  Tablets 8CT

300672030085

10300672030082

0067203008

 100008007

Excedrin® Extra Strength  Tablets 8CT New Label

300672030085

10300672030082

0067203008

 100007967

Excedrin® Migraine  Express Gel Caplets 20CT New Label

300676341200

10300676341207

0067634120

 100003178

Excedrin® Migraine Caplets 100CT

300672039910

10300672039917

0067203991

 100005998

Excedrin® Migraine Caplets 100CT Account Specific

300672039941

10300672039948

0067203994

 100008087

Excedrin® Migraine Caplets 100CT Account Specific No Carton

300672039941

10300672039948

0067203994

 100008656

Excedrin® Migraine Caplets 100CT Account Specific

300672043917

10300672043914

0067203991

 100008086

Excedrin® Migraine Caplets 100CT New Label

300672039910

10300672039917

0067203991

 100008443

Excedrin® Migraine Caplets 125CT Bonus Pack No Carton

300672039842

10300672039849

0067203984'/>"/>

SOURCE Novartis Consumer Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
2. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
3. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
4. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
5. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
6. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
9. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
10. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
11. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014  Market research firm Kalorama information says that ... Buy, in the medical device industry.  The firm thinks ... produce just 3% growth this year, which led firms ... product lines and entrance by acquisition into new competitive ... devices, The Global Market for Medical Devices, 5 ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014  The ... at the 2014 AAGL Global Congress demonstrates continued ... insert designed to provide bowel control. One of the ... Associate Professor and Division Chief of Urogynecology and ... Carolina, won an Award for Best Written Abstract ...
(Date:11/21/2014)... HILLS, Calif. , Nov. 20, 2014 Oxis ... Ken Eaton , the election of Anthony J. Cataldo ... as President. Effective November 19, 2014, Ken ... member of the Board of Directors of Oxis International, Inc. ... Cataldo has been named Chief Executive Officer of Oxis ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... SAN DIEGO--(BUSINESS WIRE)--Mar 14, 2007 - Sequenom, ... technology and,iPLEX(TM) assay were used by leading ... studies, significantly,advanced the understanding of cancer, diabetes ... studies were published in,highly recognized peer-reviewed journals ...
... Calif.--(BUSINESS WIRE)--Mar 15, 2007 - A small clinical,trial ... to find any,conclusive benefit for patients with the ... University,School of Medicine., But the results leave open ... the trial, may still be an,effective treatment for ...
Cached Medicine Technology:Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 2Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 3Stanford Study Finds No Conclusive Benefit From Treating,Kleptomania With Medication 2
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are ... announced its new collection of power suppliers. Additionally, it ... power suppliers. All the new models come with big ... until Dec. 20, 2014. , SWAccessControl.com has thousands of ... it for a long time. It is very wise ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 “BlackVue” was ... Tech Report , which features the latest and coolest ... expert and reporter for NewsWatch, conducted the product review ... unique and powerful options in the car camera industry. ... and it can be hard to find the one ...
(Date:11/23/2014)... November 23, 2014 BambooFlooringChina.com , the ... click strand woven bamboo flooring collection. Now, the ... to the company’s CEO, the promotion is valid until Dec. ... comes with a smooth and dust-free surface, which makes it ... in the industry, the company wants to make its website ...
(Date:11/22/2014)... 23, 2014 Cancer researchers in New ... between intercellular communication tunnels and the growth and spread ... story on the Surviving Mesothelioma website. , ... University of Minnesota have just released their study on ... materials between cells. They found that mesothelioma cells ...
(Date:11/22/2014)... 23, 2014 Recently, Locks-Magnetic.com , ... a new promotion of mag locks for glass doors ... attracting discount on these fresh products. Customers can get ... for glass doors are in excellent performance. Customers who ... website as soon as possible. They also can ...
Breaking Medicine News(10 mins):Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:Discounted Mag Locks for Glass Doors Revealed by Locks-Magnetic.com 2
... Goldring, a 61-year-old woman who gradually lost her eyesight to ... to create// a "seeing machine" that will enable her and ... ,The idea was born when Ms Goldring was examined ... read a word for the first time in a few ...
... anti-quota stir as they prayed to God to bless ... elite educational institutions, with wisdom. ,Junior doctors ... and Government Medical College went to Mansa Devi shrine ... give "wisdom" to those at the helm of affairs, ...
... of people having HIV/AIDS as well as tuberculosis in ... ,Launching the National TB/HIV Policy and Communication ... Health Services said that the integration of both diseases ... probably the reason TB is the leading cause of ...
... who undergo lung transplants suffer from rejection of ... have found that inhaled anti-rejection drug, cyclosporine significantly ... The study results were presented at the American ... the same study that previously found that inhaled ...
... novel study has revealed that the proton pump ... maintaining normal gastric acid levels// in those patients ... (IGH). ,Zollinger-Ellison syndrome (ZES), a rare ... development of a tumor or tumors that secrete ...
... thought that, people who actually face tough times in life, ... a startling study has revealed exactly// the contrary. A finding ... are the ones who are vulnerable to deception rather than ... study in the University's School of Psychology found that rather ...
Cached Medicine News:Health News:Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients 2Health News:Is Nexium? beneficial for patients with Zollinger-Ellison syndrome? 2Health News:Take it if you can - Tough Times in Life Churn out Greenhorns 2Health News:Take it if you can - Tough Times in Life Churn out Greenhorns 3
... Biotech Captia™ Mumps IgG Enzyme-linked Immunosorbent Assay ... quantitative determination of IgG antibody to Mumps ... may be used for the determination of ... may be used to demonstrate seroconversion or ...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in...
The DSL-05-10-MUG Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Mumps Virus in human serum. This assay is intended for in...
... Scientific Corporation announced the launch of ... the first bi-directional cooled-tip catheter available in ... catheter offers physicians the benefits of cooled ... of the Boston Scientific Blazer(R) catheter platform. ...
Medicine Products: